Pfizer: Market Still Pricing It At Crisis Valuations

Pfizer Inc. is rated a Buy with stable guidance, robust pipeline, strong free cash flows & appealing dividend yield. Learn ...

1 Incredible Reason to Buy Pfizer Stock (PFE) in November

Pfizer has long been a solid dividend payer, having raised its dividend annually for 16 years. The world's oil supply is ...

How Pfizer Stock Can Rebound

The move, announced Thursday, escalates the competition between the two pharmaceutical giants for a critical advantage in the ...
Blockonomi

Pfizer (PFE) Stock: Company Files Dual Lawsuits Against Novo Nordisk Over Metsera Deal

Pfizer files lawsuits against Novo over $9B Metsera bid, challenging 30-month timeline. Court hearing Tuesday as deadline ...

Pfizer (PFE): Is There Untapped Value in Today’s Evolving Pharmaceutical Market?

Pfizer (PFE) shares have seen some moderate movement lately, offering investors a chance to reconsider the company’s ...

Pfizer (PFE) Receives a Hold from TD Cowen

Currently, the analyst consensus on Pfizer is a Hold with an average price target of $28.60, representing a 15.98% upside. In a report released today, J.P. Morgan also maintained a Hold rating on the ...
Blockonomi

Pfizer (PFE) Stock: Pharma Giant Battles Novo Nordisk Over $9 Billion Metsera Deal

TLDR Novo Nordisk launched an unsolicited $9 billion offer for Metsera, trumping Pfizer’s existing $7.3 billion acquisition ...

4 stocks to watch on Tuesday: SBUX, UBER, PFE, MRK

Stock index futures fell sharply on Tuesday, with Nasdaq futures bottoming the pack, a day after the stock market saw an AI-tech-driven rally. Here are four stocks to watch on the day: Starbucks (SBUX ...